Novo Nordisk A/S (ADR) news

   Watch this stock
Showing stories 11 - 20 of about 131   

Articles published

NVO 54.74 +0.50 (0.92%)
price chart
Novo Nordisk A/S, Sanofi SA, Merck & Co Top $62 Billion Diabetes Market In ...
According to a report compiled by data analytics firm GlobalData, the 10 leading diabetes drug-makers generated around $62 billion in 2014 global sales, up 5.1% year-over-year (YoY).
Trending Mid-Cap Stocks in Review: Novo Nordisk A/S ADR (NVO), Paypal Holdings ...
Novo Nordisk A/S (ADR) (NYSE:NVO) fell -2.30% or -1.26 points on Monday and made its way into the losers of the day.
Best European stocks: Novo Nordisk A/S (NYSE:NVO), Royal Dutch Shell plc ...  News Oracle
Novo Nordisk Rises Pre-Bell – Seals Collaboration with Ablynx to Develop ...  The
New Deal Between Emisphere Technologies Inc. (EMIS) and Novo Nordisk A/S (ADR ...
On October 15, Emisphere Technologies Inc. (OTCMKTS:EMIS) announced an agreement with Novo Nordisk A/S (ADR) (NYSE:NVO) to develop and market oral formulations of four classes of the Danish company's investigational molecules targeting ...
Healthcare Focused Stocks: Teva Pharmaceutical Industries (NYSE:TEVA), Novo ...  Wsnews4investors
Stocks on Trader's Radar: Novo Nordisk (NVO), Chambers Street Properties ...  Techsonian (press release)
Colgate-Palmolive Company (CL), Novo Nordisk A/S (ADR) (NVO) Among Billionaire ...
The quantitative hedge fund Renaissance Technologies, formerly managed by billionaire Jim Simons, has been so successful that it has been partly responsible for prompting other funds to begin the process of looking into and setting up their own ...
CHMP Gives Positive Opinion On Novo Nordisk's Obesity Drug Saxenda
Yesterday Novo Nordisk A/S (ADR) (NYSE:NVO) said that it has received a positive verdict from the Committee for Medicinal Products for Human Use (CHMP), for its obesity drug Saxenda.
A Strong Buy Signal For These Stocks: Novo Nordisk A/S (ADR) (NYSE:NVO), BofI ...
Novo Nordisk A/S (ADR) (NYSE:NVO) added 0.81% and closed at $54.82 in the last trading session. The last trading range of the stock ranges between $54.18 and $54.86.
Hot Healthcare Stocks to Track: Novo Nordisk A/S (ADR) (NYSE:NVO), Ariad ...  Techsonian (press release)
Novo Nordisk (NVO) Wins FDA Nod For Weight-Loss Injection
Novo Nordisk A/S (ADR) (NYSE:NVO) announced Wednesday that the US Food and Drug Administration (FDA) has approved its experimental weight-loss injection, Saxenda, to treat obesity in adults.
The Newest FDA-Approved Obesity Drug Is Also the Oldest  Motley Fool
Related articles »  
Novo Nordisk To Go Ahead With Russian Investment
The world's largest insulin-maker, Novo Nordisk A/S (ADR) (NYSE:NVO) is going ahead with its investment plans for Russia, even after the ruble's drastic fall.
Best European stocks: Novo Nordisk A/S (ADR) (NYSE:NVO), Royal Dutch Shell plc ...
Novo Nordisk A/S (ADR) (NYSE:NVO) surged 0.78% and closed the last trading session at $54.38. Its 52-Week range is from $41.72 to $60.34.
Novo Nordisk A/S (ADR) (NVO): A Company Solving The Global Diabetes Crisis Is ...
Novo Nordisk A/S (NYSE: NVO) is the undisputed global leader in the diabetes market. The company's impressive product portfolio is home to five of the world's 10 best-selling diabetes medications.
Related articles »